These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33900685)

  • 1. Erythrocyte T-antigen activation in children: Patient characteristics and the hemolytic risk of transfusion.
    Jacquot C; Pary PP; Babu V; Belay E; Mo YD; Webb JL; Luban NLC; Delaney M
    Pediatr Blood Cancer; 2021 Aug; 68(8):e29082. PubMed ID: 33900685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematologic complications in a patient with Glycine soja polyagglutination following fresh frozen plasma transfusion.
    Jajosky RP; Cook LO; Manaloor E; Shikle JF; Bollag RJ
    Immunohematology; 2017 Jun; 33(2):51-55. PubMed ID: 28657762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RBC T activation and hemolysis in a neonatal intensive care population: implications for transfusion practice.
    Boralessa H; Modi N; Cockburn H; Malde R; Edwards M; Roberts I; Letsky E
    Transfusion; 2002 Nov; 42(11):1428-34. PubMed ID: 12421215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolytic anemia blunts the cytokine response to transfusion of older red blood cells in mice and dogs.
    Callan MB; Thawley VJ; Marryott KA; Shabro A; Fernando S; Kahn S; Hudson KE; Hod EA
    Transfusion; 2021 Dec; 61(12):3309-3319. PubMed ID: 34633666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe hemolysis after plasma transfusion in a neonate with necrotizing enterocolitis, Clostridium perfringens infection, and red blood cell T-polyagglutination.
    Moh-Klaren J; Bodivit G; Jugie M; Chadebech P; Chevret L; Mokhtari M; Chamillard X; Gallon P; Tissières P; Bierling P; Djoudi R; Pirenne F; Burin-des-Roziers N
    Transfusion; 2017 Nov; 57(11):2571-2577. PubMed ID: 28643465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red Blood Cell Transfusion in Patients With Autoantibodies: Is It Effective and Safe Without Increasing Hemolysis Risk?
    Park SH; Choe WH; Kwon SW
    Ann Lab Med; 2015 Jul; 35(4):436-44. PubMed ID: 26131416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion of infants with activation of erythrocyte T antigen.
    Williams RA; Brown EF; Hurst D; Franklin LC
    J Pediatr; 1989 Dec; 115(6):949-53. PubMed ID: 2585233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A severe case of atypical hemolytic uremic syndrome associated with pneumococcal infection and T activation treated successfully with plasma exchange.
    Hopkins CK; Yuan S; Lu Q; Ziman A; Goldfinger D
    Transfusion; 2008 Nov; 48(11):2448-52. PubMed ID: 18673349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
    Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
    Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Japanese multi-institutional collaborative study of antigen-positive red blood cell (RBC) transfusions in patients with corresponding RBC antibodies.
    Yamada C; Takeshita A; Ohto H; Ishimaru K; Kawabata K; Nomaguchi Y; Haraguchi Y; Abe M; Sobue K; Takenouchi H; Takadate J; Kamimura M; Katai A; Kasai D; Minami Y; Sugimoto T; Michino J; Nagai K; Kumagai M; Hasegawa Y; Ishizuka K; Ohtomo N; Yamada N; Muroi K; Matsushita T; Takahashi K
    Vox Sang; 2020 Jul; 115(5):456-465. PubMed ID: 32124460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of hemolytic transfusion reactions.
    Hendrickson JE; Fasano RM
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):704-709. PubMed ID: 34889404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hemolytic transfusion reaction caused by anti-Yt
    Raos M; Thornton N; Lukic M; Golubic Cepulic B
    Immunohematology; 2021 Mar; 37(1):13-17. PubMed ID: 33962487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between red blood cell transfusion requirements and severity of renal disease during the acute stage of hemolytic uremic syndrome.
    Cobeñas CJ; Bresso PS; Lombardi LL; Amoreo OR; Ruscasso JD; Spizzirri AP; Del C Suarez Â; Zalba JH; Rahman RC; Risso P
    Pediatr Nephrol; 2015 Dec; 30(12):2115-9. PubMed ID: 26141929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare antibody-associated hemolytic transfusion reaction and transfusion-related acute lung injury: a case report.
    Beck TN; Young NG; Erickson ML; Prats I
    BMC Surg; 2017 Apr; 17(1):48. PubMed ID: 28441942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-AnWj causing acute hemolytic transfusion reactions in a patient with aplastic anemia.
    Xu Z; Duffett L; Tokessy M; Cote J; Goldman M; Saidenberg E
    Transfusion; 2012 Jul; 52(7):1476-81. PubMed ID: 22233405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab.
    Gupta S; Fenves A; Nance ST; Sykes DB; Dzik WS
    Transfusion; 2015 Mar; 55(3):623-8. PubMed ID: 25257194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion of multiple units of Js(b+) red blood cells in the presence of anti-Jsb in a patient with sickle beta-thalassemia disease and a review of the literature.
    Yuan S; Ewing NP; Bailey D; Salvador M; Wang S
    Immunohematology; 2007; 23(2):75-80. PubMed ID: 18004938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red blood cell transfusion in patients with anti-Yt
    Wong SM; Cawthorne T; Dennington PM; Hong FS
    Transfusion; 2021 Feb; 61(2):379-384. PubMed ID: 33410173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.
    Josephson CD; Castillejo MI; Grima K; Hillyer CD
    Transfus Apher Sci; 2010 Feb; 42(1):83-8. PubMed ID: 20034854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.